Hello, Fool! | Login | Signup | My Fool
Jan 9, 2009 8:59 PM ET | Feedback | Site Changes | Help
The Company designs, develops and markets innovative aesthetic medical products based on its ELOS, technology, which uses the synergy between electrical energy and optical energy to provide effective, safe and affordable aesthetic medical treatments.
View All Commentary (ELOS)
Recs
hirshey (92.64) Submitted: 4/09/07 10:34 PM : Start Price: $25.98 ELOS Score: -32.90
EPS growth of 21.7% for the next 5 years will provide for lots of growth in the stock price. Earnings are a respectable 18x, relatively low for a biotech company. PE/Growth ratio of .53 demonstrates how undervalued the stock price currently is. Profitability-wise, the company is outperforming the industry and looks solid against the S&P 500 as well.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK